Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice

Blood

Volumn 90, Issue 8, 1997, Pages 2901-2910

  Kuefer, Martin U ^b   Look, A Thomas ^b   Pulford, Karen ^b   Behm, Frederick G ^b   Pattengale, Paul K ^b   Mason, David Y ^b   Morris, Stephan W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; NUCLEOPLASMIN; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL LYSATE; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; GENE TRANSFER; GENOTYPE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; KARYOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; MALIGNANT TRANSFORMATION; MESENTERY LYMPH NODE; METASTASIS; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

EID: 0030809095     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.2901     Document Type: Article

References (64)

1. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Tanaka H, Sasaki M, Suchi T: A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
2. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW: The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
3. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 71:31, 1989
4. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP: CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
5. Kadin ME: Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 5:25, 1994 (suppl 1)
6. Kadin ME: Ki-1/CD30+ (anaplastic) large-cell lymphoma: Maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol 12:884, 1994
7. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
8. Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T: Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA 93:4181, 1996
9. Schmidt-Zachmann MS, Hugle-Dorr B, Franke WW: A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J 6:1881, 1987
10. Schmidt-Zachmann MS, Franke WW: DNA cloning and amino acid sequence determination of a major constituent protein of mammalian nucleoli. Correspondence of the nucleoplasmin-related protein NO38 to mammalian protein B23. Chromosoma 96:417, 1988
11. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379, 1989
12. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK: Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033, 1989
13. Dumbar TS, Gentry GA, Olson MO: Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 28:9495, 1989
14. Iwahara T, Fujimoto J, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T: Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14:439, 1997
15. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14:2175, 1997
16. Bischof D, Pulford K, Mason DY, Morris SW: Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 17:2312, 1997
17. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539, 1991
18. Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G: Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
19. Sandlund JT, Pui CH, Roberts WM, Santana VM, Morris SW, Berard CW, Hutchison RE, Ribeiro RC, Mahmoud H, Crist WM: Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84:2467, 1994
20. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
21. Arber DA, Sun LH, Weiss LM: Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol 27:590, 1996
22. Offit K, Ladanyi M, Gangi MD, Ebrahim SA, Filippa D, Chaganti RS: Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625, 1990
23. Vecchi V, Burnelli R, Pileri S, Rosito P, Sabattini E, Civino A, Pericoli R, Paolucci G: Anaplastic large cell lymphoma (Ki-1+/ CD30+) in childhood. Med Pediatr Oncol 21:402, 1993
24. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Münster group studies. J Clin Oncol 12:899, 1994
25. Romaguera JE, Manning JT Jr, Tornos CS, Rodriguez J, Brooks TE, Pugh WC, Ordonez NG, Goodacre AM, Cabanillas F: Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol 5:317, 1994
26. Sandlund JT, Pui CH, Santana VM, Mahmoud H, Roberts WM, Morris S, Raimondi S, Ribeiro R, Crist WM, Lin JS: Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895, 1994
27. NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995
28. Rodrigues GA, Park M: Oncogenic activation of tyrosine kinases. Curr Opin Genet Dev 4:15, 1994
29. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-liter helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993
30. Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R, Cleary ML: Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155, 1989
31. Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR, Witte ON: BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 11:1785, 1991
32. Graham FL, van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456, 1973
33. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA: Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2:876, 1996
34. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
35. Zuniga MC, D'Eustachio P, Ruddle NH: Immunoglobulin heavy chain gene rearrangement and transcription in murine T cell hybrids and T lymphomas. Proc Natl Acad Sci USA 79:3015, 1982
36. Coleclough C, Perry RP, Karjalainen K, Weigert M: Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature 290:372, 1981
37. Caccia N, Kronenberg M, Saxe D, Haars R, Bruns GA, Goverman J, Malissen M, Willard H, Yoshikai Y, Simon M: The T cell receptor beta chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell 37:1091, 1984
38. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
39. Jones M, Cordell JL, Beyers AD, Tse AG, Mason DY: Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. J Immunol 150:5429, 1993
40. Naiem M, Gerdes J, Abdulaziz Z, Sunderland CA, Allington MJ, Stein H, Mason DY: The value of immunohistological screening in the production of monoclonal antibodies. J Immunol Methods 50:145, 1982
41. Pattengale PK, Taylor CR: Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am J Pathol 113:237, 1983
42. Pattengale PK, Frith CH: Immunomorphologic classification of spontaneous lymphoid cell neoplasms occurring in female BALB/ c mice. J Natl Cancer Inst 70:169, 1983
43. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
44. + lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437, 1996
45. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line. AMS3. Oncogene 9:1567, 1994
46. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994
47. Kamps MP, Baltimore D: E2A-Pbx 1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 13:351, 1993
48. Heard JM, Roussel MF, Rettenmier CW, Sherr CJ: Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene. Cell 51:663, 1987
49. bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
50. Gishizky ML, Johnson-White J, Witte ON: Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc Natl Acad Sci USA 90:3755, 1993
51. + anaplastic large-cell lymphoma: High frequency of c-myc proto-oncogene activation. Blood 83:3581, 1994
52. Pawson T, Gish GD: SH2 and SH3 domains: From structure to function. Cell 71:359, 1992
53. van der Geer P, Pawson T: The PTB domain: A new protein module implicated in signal transduction. Trends Biochem Sci 20:277, 1995
54. Elefanty AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 9:1069, 1990
55. Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N: Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Mol Cell Biol 11:4710, 1991
56. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, Okabe M, Suzuki M, Yamamura K, Matsuzawa Y, Kitamura Y, Kanakura Y: Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88:995, 1996
57. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88:2375, 1996
58. Gordon MY, Goldman JM: Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment. Br J Haematol 95:10, 1996
59. Elefanty AG, Cory S: Hematologic disease induced in BALB/ c mice by a bcr-abl retrovirus is influenced by the infection conditions. Mol Cell Biol 12:1755, 1992
60. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 87:6649, 1990
61. Kuefer MU, Look AT, Tripp RA, Behm FG, Pattengale PK, Morris SW: Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 88:1788a, 1996 (abstr, suppl 1)
62. Gishizky ML, Witte ON: Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science 256:836, 1992
63. Kelliher MA, Weckstein DJ, Knott AG, Wortis HH, Rosenberg N: ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice. Oncogene 8:1249, 1993
64. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, Rabbitts TH: An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 85:853, 1996